Go to main content

  1. Home
  2. Global Antimicrobial Resistance Innovation Fund (GAMRIF) – Accelerating Antibacterial Innovation with CARB-X

UK - Department of Health and Social Care (DHSC)

Global Antimicrobial Resistance Innovation Fund (GAMRIF) – Accelerating Antibacterial Innovation with CARB-X

Disclaimer: The data for this page has been produced from IATI data published by UK - Department of Health and Social Care (DHSC). Please contact them if you have any questions about their data.

Programme Data Last Updated: 27/07/2021

IATI Identifier: GB-GOV-10-GAMRIF-WP2-CARB-X

Documents

Title Doc Type Categories
Article: UK government and Bill & Melinda Gates Foundation join CARB-X partnership in fight against superbugs Objectives / Purpose of activity
Article: funding to tackle antimicrobial resistance Summary information about contract Objectives / Purpose of activity
Global AMR Innovation Fund - Programme Business Case Objectives / Purpose of activity Intended ultimate beneficiaries Budget
Global AMR Innovation Fund - Grant agreement - DHSC and Boston University Contract Conditions Objectives / Purpose of activity

This site uses cookies

We use Google Analytics to measure how you use the website so we can improve it based on user needs. Google Analytics sets cookies that store anonymised information about how you got to the site, the internal pages you visit, how long you spend on each page and what you click on while you're visiting the site. Read more